BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23584274)

  • 1. Sclerosing PEComa: a case report and review of the literature.
    Surico D; Codecà C; Boldorini R; Maldi E; Vigone A; Gentilli S; Surico N
    Minerva Chir; 2013 Feb; 68(1):125-8. PubMed ID: 23584274
    [No Abstract]   [Full Text] [Related]  

  • 2. Sclerosing stromal tumour of the ovary associated with Meigs' syndrome and elevated CA125.
    Amorim-Costa C; Costa A; Baptista P; Paiva V
    J Obstet Gynaecol; 2010; 30(7):747-8. PubMed ID: 20925634
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary Ovarian Malignant PEComa: A Case Report.
    Westaby JD; Magdy N; Fisher C; El-Bahrawy M
    Int J Gynecol Pathol; 2017 Jul; 36(4):400-404. PubMed ID: 27684885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three synchronous primary pelvic cancers--a case report.
    Căpîlna ME; Rusu SC; Szabo B; Marian C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):107-10. PubMed ID: 24741785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary fallopian tube carcinoma with metastasis in the contralateral ovary.
    Aich RK; Dasgupta S; Chakraborty B; Karim R; Bhattacharya J; Sen P
    J Indian Med Assoc; 2012 Jul; 110(7):494-5, 498. PubMed ID: 23520679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue polypeptide specific antigen (TPS) and carbohydrate antigen 125 (CA-125) in the early prediction of recurrent ovarian cancer.
    Yeh LS; Hung YC; Kao A; Lin CC; Lee CC
    Anticancer Res; 2002; 22(6B):3669-71. PubMed ID: 12552974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
    Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
    Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early stage fallopian tube carcinoma--diagnosis, staging and treatment].
    Ben-Ami I; Halperin R; Herman A; Schneider D
    Harefuah; 2004 Nov; 143(11):790-3, 839. PubMed ID: 15603266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum tumor markers CA125 and HE4 in ovarian cancer patients].
    Sergeeva NS; Marshutina NV; Alentov II; Korneeva IA; Novikova EG
    Vopr Onkol; 2013; 59(2):12-21. PubMed ID: 23814844
    [No Abstract]   [Full Text] [Related]  

  • 10. Perivascular epithelioid cell tumor (PEComa) of the pancreas: immunoelectron microscopy and review of the literature.
    Hirabayashi K; Nakamura N; Kajiwara H; Hori S; Kawaguchi Y; Yamashita T; Dowaki S; Imaizumi T; Osamura RY
    Pathol Int; 2009 Sep; 59(9):650-5. PubMed ID: 19712133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary ovarian trabecular carcinoid tumor: a case report and literature review.
    Bai X; Li N; Wang F; Li S; Yu Q
    Arch Gynecol Obstet; 2010 Oct; 282(4):407-11. PubMed ID: 20652280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological features of uterine neoplasms with perivascular epithelioid cell differentiation].
    Lu HZ; Zhang HT; Liu XY; Xue XH; Xie YQ; Liu SM; Su Q
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):213-6. PubMed ID: 19615263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant perivascular epithelioid cell tumor of the mesentery: a case report and literature review.
    Lai CL; Hsu KF; Yu JC; Chen CJ; Hsieh CB; Chan DC; Li HS; Hsu HM
    Onkologie; 2012; 35(3):114-7. PubMed ID: 22414975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder perivascular epithelioid cell tumor (PEComa): a case report and literature review.
    Sarti A; Rubilotta E; Balzarro M; Cerruto MA; Brunelli M; Artibani W
    Urologia; 2015; 82(2):120-3. PubMed ID: 24557821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
    BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA-125: a biomarker put to the test.
    Schmidt C
    J Natl Cancer Inst; 2011 Sep; 103(17):1290-1. PubMed ID: 21852262
    [No Abstract]   [Full Text] [Related]  

  • 17. Sclerosing variant of perivascular epithelioid cell tumor in the female genital organs.
    Yamada Y; Yamamoto H; Ohishi Y; Nishiyama K; Fukuhara M; Saitou T; Tsuneyoshi M; Oda Y
    Pathol Int; 2011 Dec; 61(12):768-72. PubMed ID: 22126387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The characteristics of CA125/MUC16].
    Hiraike O; Yano T; Taketani Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():681-4. PubMed ID: 20960850
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of dermatomyositis with fallopian tube carcinoma: A potential paraneoplastic syndrome.
    Peitsidis P; Peitsidou A; Papadimitriou C; Rodolakis A; Tsekoura V; Akrivos T
    J Obstet Gynaecol; 2008 Apr; 28(3):365-6. PubMed ID: 18569502
    [No Abstract]   [Full Text] [Related]  

  • 20. The prognostic value of CA-125 in epithelial ovarian cancer patients during and after chemotherapy.
    Lukácskó I; Hernádi Z; Sápy T; Borsos A
    Acta Chir Hung; 1997; 36(1-4):213-4. PubMed ID: 9408350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.